The BARD1 C-terminal domain structure and interactions with polyadenylation factor CstF-50

Biochemistry

Volumn 47, Issue 44, 2008, Pages 11446-11456

  Edwards, Ross A ^a   Lee, Megan S ^a   Tsutakawa, Susan E ^b   Williams, R Scott ^c   Tainer, John A ^b,c   Glover, J N Mark ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABS RESINS; AMINO ACIDS; BINDING ENERGY; BIOCHEMISTRY; CELL DEATH; CRYSTAL STRUCTURE; DNA; ELASTICITY; FLOW INTERACTIONS; GENES; NUCLEIC ACIDS; ORGANIC ACIDS; PLASTICITY; PLASTICS; PORT TERMINALS; RNA;

ANKYRIN; APOPTOSIS; BARD1 BRCT DOMAINS; BINDING POCKETS; BRCT DOMAINS; DELETION MUTANTS; DNA DAMAGE SIGNALS; DNA DAMAGES; DO-MAINS; FLEXIBLE TETHERS; LIMITED PROTEOLYSES; MULTIPLE BINDING SITES; PHOSPHOPEPTIDE; POLYADENYLATION FACTORS; RNA POLYMERASES; SMALL ANGLE X-RAY SCATTERINGS; STRUCTURAL PLASTICITIES; TERMINAL DOMAINS;

BINDING SITES;

ANKYRIN; BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; HYBRID PROTEIN; PROTEIN CSTF 50; PROTEIN P53; RNA POLYMERASE II; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; DNA DAMAGE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; RADIATION SCATTERING; RNA PROCESSING; TANDEM REPEAT;

BINDING SITES; CLEAVAGE STIMULATION FACTOR; CRYSTALLOGRAPHY, X-RAY; DNA DAMAGE; HUMANS; MODELS, MOLECULAR; POLYADENYLATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; RNA PROCESSING, POST-TRANSCRIPTIONAL; SCATTERING, SMALL ANGLE; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; X-RAY DIFFRACTION;

EID: 55249094317     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi801115g     Document Type: Article

References (75)

1. Scully, R., Xie, A., and Nagaraju, G. (2004) Molecular functions of BRCA1 in the DNA damage response. Cancer Biol. Ther. 3, 521-527.
2. Irminger-Finger, I., and Leung, W. C. (2002) BRCA1-dependent and independent functions of BARD1. Int. J. Biochem. Cell Biol. 34, 582-587.
3. Wu, L. C., Wang, Z. W., Tsan, J. T., Spillman, M. A., Phung, A., Xu, X. L., Yang, M. C., Hwang, L. Y., Bowcock, A. M., and Baer, R. (1996) Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat. Genet. 14, 430-440.
4. Brzovic, P. S., Keeffe, J. R., Nishikawa, H., Miyamoto, K., Fox, D., III, Fukuda, M., Ohta, T., and Klevit, R. (2003) Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex. Proc. Natl. Acad. Sci. U.S.A. 100, 5646-5651.
5. Brzovic, P. S., Rajagopal, P., Hoyt, D. W., King, M. C., and Klevit, R. E. (2001) Structure of a BRCA1-BARD1 heterodimeric RING-RING complex. Nat. Struct. Biol. 8, 833-837.
6. Bork, P., Hofmann, K., Bucher, P., Neuwald, A. F., Altschul, S. F., and Koonin, E. V. (1997) A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J. 11, 68-76.
7. Callebaut, I., and Mornon, J. P. (1997) From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS Lett. 400, 25-30.
8. Glover, J. N., Williams, R. S., and Lee, M. S. (2004) Interactions between BRCT repeats and phosphoproteins: tangled up in two. Trends Biochem. Sci. 29, 579-585.
9. Cantor, S. B., Bell, D. W., Ganesan, S., Kass, E. M., Drapkin, R., Grossman, S., Wahrer, D. C., Sgroi, D. C., Lane, W. S., Haber, D. A., and Livingston, D. M. (2001) BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105, 149-160.
10. Yu, X., Wu, L. C., Bowcock, A. M., Aronheim, A., and Baer, R. (1998) The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression. J. Biol. Chem. 273, 25388-25392.
11. Li, S., Chen, P. L., Subramanian, T., Chinnadurai, G., Tomlinson, G., Osborne, C. K., Sharp, Z. D., and Lee, W. H. (1999) Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damage. J. Biol. Chem. 274, 11334-11338.
12. Kim, H., Huang, J., and Chen, J. (2007) CCDC98 is a BRCA1-BRCT domain-binding protein involved in the DNA damage response. Nat. Struct. Mol. Biol. 14, 710-715.
13. Liu, Z., Wu, J., and Yu, X. (2007) CCDC98 targets BRCA1 to DNA damage sites. Nat. Struct. Mol. Biol. 14, 716-720.
14. Manke, I. A., Lowery, D. M., Nguyen, A., and Yaffe, M. B. (2003) BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science 302, 636-639.
15. Yu, X., Chini, C. C., He, M., Mer, G., and Chen, J. (2003) The BRCT domain is a phospho-protein binding domain. Science 302, 639-642.
16. Williams, R. S., Lee, M. S., Hau, D. D., and Glover, J. N. (2004) Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1. Nat. Struct. Mol. Biol. 11, 519-525.
17. Clapperton, J. A., Manke, I. A., Lowery, D. M., Ho, T., Haire, L. F., Yaffe, M. B., and Smerdon, S. J. (2004) Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer. Nat. Struct. Mol. Biol. 11, 512-518.
18. Shiozaki, E. N., Gu, L., Yan, N., and Shi, Y. (2004) Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: implications for signaling. Mol. Cell 14, 405-412.
19. Varma, A. K., Brown, R. S., Birrane, G., and Ladias, J. A. (2005) Structural basis for cell cycle checkpoint control by the BRCA1-CtIP complex. Biochemistry 44, 10941-10946.
20. Lee, M. S., Edwards, R. A., Thede, G. L., and Glover, J. N. (2005) Structure of the BRCT repeat domain of MDC1 and its specificity for the free COOH-terminal end of the gamma-H2AX histone tail. J. Biol. Chem. 280, 32053-32056.
21. Williams, R. S., and Glover, J. N. (2003) Structural consequences of a cancer-causing BRCA1-BRCT missense mutation. J. Biol. Chem. 278, 2630-2635.
22. Tischkowitz, M., Hamel, N., Carvalho, M. A., Birrane, G., Soni, A., van.Beers, E. H., Joosse, S. A., Wong, N., Novak, D., Quenneville, L. A., Grist, S. A., Nederlof, P. M., Goldgar, D. E., Tavtigian, S. V., Monteiro, A. N., Ladias, J. A. and, and Foulkes, W. D. (2008) Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide- binding pocket: a multi-modal approach. Eur. J. Hum. Genet. (in press).
23. Rodriguez, M., Yu, X., Chen, J., and Songyang, Z. (2003) Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains. J. Biol. Chem. 278, 52914-52918.
24. Kim, H., Chen, J., and Yu, X. (2007) Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response. Science 316, 1202-1205.
25. Sedgwick, S. G., and Smerdon, S. J. (1999) The ankyrin repeat: a diversity of interactions on a common structural framework. Trends Biochem. Sci. 24, 311-316.
26. Mosavi, L. K., Cammett, T. J., Desrosiers, D. C., and Peng, Z. Y. (2004) The ankyrin repeat as molecular architecture for protein recognition. Protein Sci. 13, 1435-1448.
27. Laufer, M., Nandula, S. V., Modi, A. P., Wang, S., Jasin, M., Murty, V. V., Ludwig, T., and Baer, R. (2007) Structural requirements for the BARD1 tumor suppressor in chromosomal stability and homology-directed DNA repair. J. Biol. Chem. 282, 34325-34333.
28. Thai, T. H., Du, F., Tsan, J. T., Jin, Y., Phung, A., Spillman, M. A., Massa, H. F., Muller, C. Y., Ashfaq, R., Mathis, J. M., Miller, D. S., Trask, B. J., Baer, R., and Bowcock, A. M. (1998) Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers. Hum. Mol. Genet. 7, 195-202.
29. Ghimenti, C., Sensi, E., Presciuttini, S., Brunetti, I. M., Conte, P., Bevilacqua, G., and Caligo, M. A. (2002) Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations. Genes Chromosomes Cancer 33, 235-242.
30. Sauer, M. K., and Andrulis, I. L. (2005) Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer. J. Med. Genet. 42, 633-638.
31. Kleiman, F. E., Wu-Baer, F., Fonseca, D., Kaneko, S., Baer, R., and Manley, J. L. (2005) BRCA1/BARD1 inhibition of mRNA 3′ processing involves targeted degradation of RNA polymerase II. Genes Dev. 19, 1227-1237.
32. Kleiman, F. E., and Manley, J. L. (2001) The BARD1-CstF-50 interaction links mRNA 3′ end formation to DNA damage and tumor suppression. Cell 104, 743-753.
33. Kleiman, F. E., and Manley, J. L. (1999) Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50. Science 285, 1576-1579.
34. Mirkin, N., Fonseca, D., Mohammed, S., Cevher, M. A., Manley, J. L., and Kleiman, F. E. (2008) The 3′ processing factor CstF functions in the DNA repair response. Nucleic Acids Res. (in press).
35. Takagaki, Y., and Manley, J. L. (2000) Complex protein interactions within the human polyadenylation machinery identify a novel component. Mol. Cell. Biol. 20, 1515-1525.
36. Vagin, A., and Teplyakov, A. (1997) MOLREP: an automated program for molecular replacement. J. Appl. Crystallogr. 30, 1022-1025.
37. Murshudov, G. N., Vagin, A. A., and Dodson, E. J. (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr., Sect. D: Biol. Crystallogr. 53, 240-255.
38. Winn, M., Isupov, M., and Murchudov, G. N. (2001) Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr., Sect. D: Biol. Crystallogr. 57, 122-133.
39. Brunger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse.Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr., Sect. D: Biol. Crystallogr. 54, 905-921.
40. Emsley, P., and Cowtan, K. (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr., Sect. D: Biol. Crystallogr. 60, 2126-2132.
41. Putnam, C. D., Hammel, M., Hura, G. L., and Tainer, J. A. (2007) X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution. Q. Rev. Biophys. 40, 191-285.
42. Tsutakawa, S. E., Hura, G. L., Frankel, K. A., Cooper, P. K., and Tainer, J. A. (2007) Structural analysis of flexible proteins in solution by small angle X-ray scattering combined with crystallography. J. Struct. Biol. 158, 214-223.
43. Konarev, P. V., Volkov, V. V., Sokolova, A. V., Koch, M. H. J., and Svergun, D. I. (2003) PRIMUS: a Windows PC-based system for small-angle scattering data analysis. J. Appl. Crystallogr. 36, 1277-1282.
44. Svergun, D. I. (1992) Determination of the regularization parameter in indirect-transform methods using perceptual criteria. J. Appl. Crystallogr. 25, 495-503.
45. Kikhney, A. G., Konarev, P. V., and Svergun, D. I.
46. Svergun, D. I. (1999) Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. Biophys. J. 76, 2879-2886.
47. Svergun, D. I., Petoukhov, M. V., and Koch, M. H. (2001) Determination of domain structure of proteins from X-ray solution scattering. Biophys. J. 80, 2946-2953.
48. Kozin, M. B., and Svergun, D. I. (2001) Automated matching of high- and low-resolution structural models. J. Appl. Crystallogr. 34, 33-41.
49. Volkov, V. V., and Svergun, D. I. (2003) Uniqueness of ab initio shape determination in small-angle scattering. J. Appl. Crystallogr. 36, 860-864.
50. Bates, P. A., Kelley, L. A., MacCallum, R. M., and Sternberg, M. J. (2001) Enhancement of protein modeling by human intervention in applying the automatic programs 3D-JIGSAW and 3D-PSSM. Proteins Suppl. 5, 39-46.
51. Bates, P. A., and Sternberg, M. J. (1999) Model building by comparison at CASP3: using expert knowledge and computer automation. Proteins Suppl. 3, 47-54.
52. Contreras-Moreira, B., and Bates, P. A. (2002) Domain fishing: a first step in protein comparative modelling. Bioinformatics 18, 1141-1142.
53. Bernado, P., Mylonas, E., Petoukhov, M. V., Blackledge, M., and Svergun, D. I. (2007) Structural characterization of flexible proteins using small-angle X-ray scattering. J. Am. Chem. Soc. 129, 5656-5664.
54. Williams, R. S., Green, R., and Glover, J. N. (2001) Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1. Nat. Struct. Biol. 8, 838-842.
55. Birrane, G., Varma, A. K., Soni, A., and Ladias, J. A. (2007) Crystal structure of the BARD1 BRCT domains. Biochemistry 46, 7706-7712.
56. Stucki, M., Clapperton, J. A., Mohammad, D., Yaffe, M. B., Smerdon, S. J., and Jackson, S. P. (2005) MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell 123, 1213-1226.
57. Kim, H. S., Li, H., Cevher, M., Parmelee, A., Fonseca, D., Kleiman, F. E., and Lee, S. B. (2006) DNA damage-induced BARD1 phosphorylation is critical for the inhibition of messenger RNA processing by BRCA1/BARD1 complex. Cancer Res. 66, 4561-4565.
58. Porod, G. (1982) Small Angle X-Ray Scattering, Academic, London.
59. Pollack, L., Tate, M. W., Darnton, N. C., Knight, J. B., Gruner, S. M., Eaton, W. A., and Austin, R. H. (1999) Compactness of the denatured state of a fast-folding protein measured by submillisecond small-angle x-ray scattering. Proc. Natl. Acad. Sci. U.S.A. 96, 10115-10117.
60. Wriggers, W., and Chaon, P. (2001) Using Situs for the registration of protein structures with low-resolution bead models from X-ray solution scattering. J. Appl. Crystallogr. 34, 773-776.
61. Mosavi, L. K., Minor, D. L., Jr., and Peng, Z. Y. (2002) Consensus-derived structural determinants of the ankyrin repeat motif. Proc. Natl. Acad. Sci. U.S.A. 99, 16029-16034.
62. Fox, D., Le Trong, I., Rajagopal, P., Brzovic, P. S., Stenkamp, R. E., and Klevit, R. E. (2008) Crystal structure of the BARD1 ankyrin repeat domain and its functional consequences. J. Biol. Chem. (in press).
63. Svergun, D. I., and Koch, M. H. J. (2003) Small-angle scattering studies of biological macromolecules in solution.
64. Bernado, P., Perez, Y., Svergun, D. I., and Pons, M. (2008) Structural characterization of the active and inactive states of Src kinase in solution by small-angle X-ray scattering. J. Mol. Biol. 376, 492-505.
65. Pascal, J. M., Tsodikov, O. V., Hura, G. L., Song, W., Cotner, E. A., Classen, S., Tomkinson, A. E., Tainer, J. A., and Ellenberger, T. (2006) A flexible interface between DNA ligase and PCNA supports conformational switching and efficient ligation of DNA. Mol. Cell 24, 279-291.
66. Shell, S. S., Putnam, C. D., and Kolodner, R. D. (2007) The N terminus of Saccharomyces cerevisiae Msh6 is an unstructured tether to PCNA. Mol. Cell 26, 565-578.
67. Gaudet, R., Bohm, A., and Sigler, P. B. (1996) Crystal structure at 2.4 angstroms resolution of the complex of transducin betagamma and its regulator, phosducin. Cell 87, 577-588.
68. Wall, M. A., Coleman, D. E., Lee, E., Iniguez-Lluhi, J. A., Posner, B. A., Gilman, A. G., and Sprang, S. R. (1995) The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2. Cell 83, 1047-1058.
69. Shin, D. S., Pellegrini, L., Daniels, D. S., Yelent, B., Craig, L., Bates, D., Yu, D. S., Shivji, M. K., Hitomi, C., Arvai, A. S., Volkmann, N., Tsuruta, H., Blundell, T. L., Venkitaraman, A. R., and Tainer, J. A. (2003) Full-length archaeal Rad51 structure and mutants: mechanisms for RAD51 assembly and control by BRCA2. EMBO J. 22, 4566-4576.
70. Fong, N., and Bentley, D. L. (2001) Capping, splicing, and 3′ processing are independently stimulated by RNA polymerase II: different functions for different segments of the CTD. Genes Dev. 15, 1783-1795.
71. McCracken, S., Fong, N., Yankulov, K., Ballantyne, S., Pan, G., Greenblatt, J., Patterson, S. D., Wickens, M., and Bentley, D. L. (1997) The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. Nature 385, 357-361.
72. Fabbro, M., Savage, K., Hobson, K., Deans, A. J., Powell, S. N., McArthur, G. A., and Khanna, K. K. (2004) BRCA1-BARD1 complexes are required for p53Ser-15 phosphorylation and a G1/S arrest following ionizing radiation-induced DNA damage. J. Biol. Chem. 279, 31251-31258.
73. Feki, A., Jefford, C. E., Berardi, P., Wu, J. Y., Cartier, L., Krause, K. H., and Irminger-Finger, I. (2005) BARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinase. Oncogene 24, 3726-3736.
74. Irminger-Finger, I., Leung, W. C., Li, J., Dubois-Dauphin, M., Harb, J., Feki, A., Jefford, C. E., Soriano, J. V., Jaconi, M., Montesano, R., and Krause, K. H. (2001) Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis. Mol. Cell 8, 1255-1266.
75. Perry, J. J., Fan, L., and Tainer, J. A. (2007) Developing master keys to brain pathology, cancer and aging from the structural biology of proteins controlling reactive oxygen species and DNA repair. Neuroscience 145, 1280-1299.